#Gastrointestinal MedTech

[medi-techinsights]

Global Gastrointestinal Devices MedTech Market valued at USD 13-14 billion in 2021, is growing at a rate of 5%

Aging population, rising number of GI procedures, increasing cases of colorectal cancer and screening mandates in many healthcare systems is driving the growth of Gastrointestinal Devices MedTech market. Rising usage of robotics and focus on AI are offering further impetus for the market growth.

Medi-Tech Insights’ latest report on Gastrointestinal Devices MedTech market analyses the global market with respect to product and geography.

Based on product, the Gastrointestinal Devices MedTech market comprises of 4 segments, viz., GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic devices. Based on our research & interviews with industry experts, it is evident that GI endoscopes is the largest product segment. Within endoscope market, reusable endoscopes form major chunk of the market, owing to the fact that they are high-cost capital equipment with relatively greater adoption. However, single-use endoscope market is slated to grow faster. Shift driven by relatively lower acquisition cost, lower level of training & skills, no reprocessing cost and no risk of cross-contamination. Major players offering single-use endoscopes are Boston Scientific and Ambu.

“Currently, penetration of single-use endoscopes in GI is <5%. It is expected to increase to 10-15% in the next 5 years.” - CEO, Leading Gastrointestinal MedTech Company

Geographic Analysis: Gastrointestinal Devices MedTech Market

Comprehensive regional and country-level assessment of the global Gastrointestinal Devices MedTech market covering U.S., Europe, Asia-Pacific and Rest of the World suggests that U.S. is likely to dominate the market next 5 years while China will grow faster compared to other geographies.

Gastrointestinal Devices MedTech market benefits from presence of large players like Olympus and Boston Scientific (BSX) but number of start-up companies have emerged especially in AI, single-use instruments.

GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic devices are four major market segments. Olympus, Fujifilm, and Hoya are top 3 players in endoscope market with Olympus alone accounting for major chunk. Endotherapy devices is the fastest growing market segment and is dominated by BSX with more than 50% market share. Laparoscope’s market is dominated by Stryker, Karl Storz, and Olympus. On the other hand, top 5 players accounted for more than 70% share of laparoscopic devices market.

Artificial intelligence (AI) and Single-Use Endoscopy have attracted Private Equity investments

Traditional endoscopy has a long track record in healthcare, but the images produced by the procedure are subject to the assessment of clinicians, potentially leading to wide variations in interpretations. However, AI-assisted endoscopy is perceived to have potential to provide consistent results and improve patient care owing to which PEs are investing in AI providers. For instance, in August 2021, Iterative Scopes raised $30 mi Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology. Similarly, single-use endoscopy is likely to be focus area in coming years with key players already started to add these to portfolio. Also, smaller/niche players are receiving funding. For instance, in October 2021, IQ endoscope received £4 mi (~$5 mi) for supporting regulatory approval process for its single use flexible gastroscope, as well as accelerating the development of its single use flexible colonoscope.

Get Customized Research Report on GI MedTech market @ https://meditechinsights.com/gastrointestinal-devices-medtech-market/

[meditech-insights]

Global Gastrointestinal Devices MedTech Market valued at $13–14 billion in 2021 and is expected to grow at a CAGR of 5% by 2026

The growth of the Gastrointestinal Devices MedTech market is being driven by an ageing population, an increase in GI procedures, an increase in cases of colorectal cancer, and screening requirements in many healthcare systems. Growing robotics use and focus to AI are providing further momentum for market expansion.

Global Gastrointestinal Devices MedTech market pegged at $13-14 billion in 2021, growing at a rate of 5%. Increased usage of single-use endoscopes, robots, and an increasing focus on AI in surgeries will be the main drivers of market expansion.

Medi-Tech Insights’ latest research report on Gastrointestinal Devices MedTech market analyses the worldwide market with respect to product and geography.

The Gastrointestinal Devices MedTech market is divided into four product-specific segments: GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic devices. It is evident from our research and interviews with industry professionals that the largest product segment is GI endoscopes. Within endoscope market, reusable endoscopes form major chunk of the market, owing to the fact that they are high-cost capital equipment with relatively greater adoption. However, single-use endoscope market is anticipated to expand more quickly. Shift driven by relatively lower acquisition cost, lower level of training & skills, no reprocessing cost and no risk of cross-contamination. Ambu and Boston Scientific are two major companies that offer single-use endoscopes.

“Currently, penetration of single-use endoscopes in GI is <5%. It is expected to increase to 10-15% in the next 5 years.”- CEO, Leading Gastrointestinal MedTech Company

Geographic Snapshot: Gastrointestinal Devices MedTech Market

Comprehensive regional and country-level assessment of the global Gastrointestinal Devices MedTech market covering U.S., Europe, Asia-Pacific and Rest of the World indicates that the U.S. is likely to dominate the market over the next five years while China will grow faster than other geographic areas.

Explore Premium Report on Gastrointestinal Devices MedTech Market @ https://meditechinsights.com/gastrointestinal-devices-medtech-market/

Gastrointestinal Devices MedTech market benefits from presence of large players like Olympus and Boston Scientific (BSX) but number of start-up companies have emerged especially in AI, single-use instruments

Four significant market segments are GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic equipment. The top 3 endoscope companies are Olympus, Fujifilm, and Hoya with Olympus alone accounting for major chunk. Endotherapy devices is the fastest increasing market segment and is dominated by BSX with more than 50% market share. Laparoscope’s market is dominated by Stryker, Karl Storz, and Olympus. On the other hand, top 5 players accounted for more than 70% share of laparoscopic devices market.

Artificial intelligence (AI) and single-use endoscopy have attracted PE investment recently

Traditional endoscopy has a long history in healthcare, however the images produced by the procedure are assessed by clinicians, which might result in a wide range of interpretations. However, AI-assisted endoscopy is perceived to have potential to provide consistent results and improve patient care owing to which PEs are investing in AI providers. For instance, in August 2021, Iterative Scopes raised $30 mi Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology. Similar to this, single-use endoscopy is expected to be a priority area in the next years as major players have already begun to include them to their portfolios. Also, smaller/niche players are receiving funding. For instance, in October 2021, IQ endoscope received £4 mi (~$5 mi) for supporting regulatory approval process for its single use flexible gastroscope, as well as accelerating the development of its single use flexible colonoscope.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[atanasat]

Gastrointestinal-resident, shape-changing microdevices extend drug release in vivo  

https://digitalpatientsafety.com/gastrointestinal-resident-shape-changing-microdevices-extend-drug-release-in-vivo/  

#DHPSP #MedTech #HealthTech

[reportwire]

Endoscopic AI maker AI Medical Service scores $70M in Series C funding

Endoscopic AI maker AI Medical Service scores $70M in Series C funding

Japanese medtech firm AI Medical Service has raised 8 billion yen ($70 million) in a Series C funding round led by Masayoshi Son’s SoftBank Vision Fund 2, along with other existing investors Globis Capital Partners, World Innovation Lab, and Incubate Fund. AIM develops an AI decision support tool for endoscopists who are screening for abnormalities, including signs of gastrointestinal cancer, in…

[chitrakullkarni]

Surgical Robot Market Competitive Environment & Distribution Channel Analysis, 2024

The global Surgical Robot Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

Global Surgical Robot Market is anticipated to grow considerably in the forecast period owing to the growth in (MIS) Minimally Invasive Surgery worldwide. Surgical robots are sophisticated robots that carry out medical procedures on patients. These systems potentially improve the safety and perform surgeries effectively. These systems support major advances like minimally invasive surgery, remote surgery, and unmanned surgery.

Key Players:

Intuitive Surgical, Inc.

Accuray

Stryker Corporation/MAKO

Medtech Surgical

Hansen Medical

Medrobotics Corporation

TransEnterix

Titan Medical, Inc.

Renishaw Plc

OR Productivity Plc

Mazor Robotics

Varian Medical Systems

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/surgical-robots-market/request-sample

Growth Drivers:

Surgical robots market is driven by factors like growing geriatric population, increasing chronic conditions, complexities of surgical treatments, rising need for healthcare automation and growing economic growth. However, the market of surgical robot is facing obstructions due to the challenges of laparoscope control and risks associated with robotic surgery.

While the concept of surgical robots is still uncommon in most places, several hospitals are accepting robotic systems. Adoption of Nano and micro robots for urological surgeries, emphasis on development of cost-efficient robot systems, growing research & development, and wide use of robots in general procedures are the remarkable trends observed in the surgical robot industry. However, high capital is a major challenge surgical robot market faces.

Product Outlook:

Robot System

Instrument & Accessories

Services

Accessories segment is predicted to rise substantially due to extensive use of accessories in several surgeries. Also, in terms of revenue the segment is expected to witness progressive growth rate.

Application Outlook:

General Surgery

Urology

Orthopedic

Neurosurgery

Cardiovascular

Gynecology

Radiology

Transplant

Gastrointestinal

Brand Outlook:

da Vinci Surgical System

CyberKnife

ROSA

MAKO

Renaissance

Regional Outlook:

Geographically, surgical robots industry is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Owing to the increasing acceptance of surgical robot systems in various healthcare institutions and advanced healthcare infrastructure, North America dominated the market of surgical robot in the past years and is expected to continue its dominance in future as well.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

[sandlerresearch]

Colorectal Cancer Screening Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) published on

https://www.sandlerresearch.org/colorectal-cancer-screening-test-in-vitro-diagnostics-global-market-analysis-and-forecast-model-covid-19-market-impact.html

Colorectal Cancer Screening Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Colorectal Cancer Screening Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Summary

Colorectal Cancer Screening Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Colorectal Cancer Screening Tests market for the year 2020 and beyond. Coverage and participation rates of CRC screening plans vary considerably depending on the country. In general, CRC screening is recommended for individuals aged 50-75 years of age.

Fecal occult blood tests are sometimes performed for diagnostic purposes in symptomatic patients with indications such as anaemia, iron-deficiency, abdominal pain, altered bowel habits, and suspected gastrointestinal bleeding.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Colorectal Cancer Screening Tests and evolving competitive landscape – – Insightful review of the key industry trends. – Annualized total Colorectal Cancer Screening Tests market revenue by segment and market outlooks from 2015-2030. – Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights – – Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. – SWOT analysis for Colorectal Cancer Screening Tests market. – Competitive dynamics insights and trends provided for Colorectal Cancer Screening Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. – Country specific overview of the healthcare system. – Country specific reimbursement policies. – Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Exact Sciences Corp, Eiken Chemical Co Ltd, HemoCue AB , Kyowa Medex Co., Ltd , Alfresa Pharma Corp, Sentinel Diagnostics , Hemosure Inc and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – – CMO executives who must have deep understanding of the Colorectal Cancer Screening Tests market place to make strategic planning and investment decisions. – Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. – Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to – – Understand the impact of COVID-19 on Colorectal Cancer Screening Tests market. – Develop and design you’re in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. – Develop business strategies by understanding the trends shaping and driving Colorectal Cancer Screening Tests market. – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Colorectal Cancer Screening Tests market in the future. – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders. – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. – Track device sales in the global and country-specific Colorectal Cancer Screening Tests market from 2015-2030. – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

[kathatjaag]

Olympus plans to start with ENDO-AID’s commercial launch in Europe this November, followed by expansions into certain Middle Eastern, African and Asia-Pacific countries. (Olympus) Olympus has begun rolling out an artificial-intelligence-powered platform for its new endoscope, designed to automatically spot suspicious lesions and polyps during a colonoscopy in real time. The ENDO-AID program works in combination with the company’s Evis X1, which it launched in April. The AI’s machine-learning algorithm highlights areas of interest whenever a lesion appears on the video screen, including potential cancers and benign tumors. Olympus also described plans to expand the technology’s use to other therapy and screening areas in the future, including for inspections of the esophagus, stomach and other gastrointestinal organs. “Especially in AI, we recognize the power of elevating endoscopic imaging to uncharted levels,” said Frank Drewalowski, head of Olympus’ endoscopic solutions division.…

[meditech-insights]

Gastrointestinal Endoscopic Devices Market was estimated at $13.7 billion in 2021 and is anticipated to increase at a CAGR of 5% by 2026

Disorders of the digestive system known as Gastrointestinal (GI) diseases that involve a variety of vital digestive organs such as mouth, esophagus, stomach, small and large bowels, rectum, anus, and GI connected organs (liver, gallbladder, and pancreas).

Medical devices such as endoscopes, laparoscopes/surgical endoscopes, endotherapy devices, and laparoscopic devices play an important role in the early & accurate diagnosis and treatment of potentially life-threatening GI diseases, which in turn opens up growth avenues for GI MedTech device manufacturers.

The Global Gastrointestinal MedTech Devices Market was valued at $13.7 billion in 2021 and is set to witness a growth rate of 5% in the next 5 years. Some of the key factors driving the global gastrointestinal endoscopic devices market include growing number of GI procedures, increasing preference for minimally invasive surgeries, rising acceptance of single-use devices to prevent patient cross-contamination and ensure patient safety, increasing cases of colorectal cancer and screening mandates in most healthcare systems, rising hospital investments in endoscopy facilities, and benefits of endoscopic procedures.

The Recovery of Gastrointestinal Endoscopic Devices Market Post Covid-19

Covid-19 had a detrimental effect on health services globally and the GI MedTech industry was no different.

Covid-19 has a direct impact on a number of specialties, including gastroenterology. The pandemic adversely impacted the workflow and safety of endoscopists, ancillary staff, and patients. Lacks of personal protective equipment (PPE), curtailed patient volume, dearth of testing kits, workforce furloughs, and lockdowns forced units to drastically reduce the volume of the procedures, postpone and even cancel GI procedures in medium- to low-risk cases. The dip in the number of GI procedures resulted in the decline of Gastrointestinal Endoscopic Devices market revenues.

Though, since 2021, the Gastrointestinal Endoscopic Devices is on the recovery path. The market has been driven by the strong performance of GI MedTech companies in Japan, Europe, and North America, increased sales of gastroscopes and colonoscopes, the launch of innovative products, strong performance of the GI MedTech device manufacturers in North America, improving Covid-19 coverage globally and increasing number of GI procedures.

“A price erosion in Gastrointestinal Endoscopic Devices is expected due to consolidation of group purchasing organizations (GPOs) in different markets and demand of discounts by cash-strapped hospitals in high volume purchases especially due to Covid-19 pandemic.” - Senior Director, Leading Endoscope Manufacturer, United States

Explore Premium Report on Gastrointestinal Endoscopic Devices Market @ https://meditechinsights.com/gastrointestinal-endoscopic-devices-market/

The Gastrointestinal MedTech Devices Market is being driven by Technological Advancements

The Gastrointestinal Endoscopic Devices market is a technology-driven market and is characterised by constant product enhancements/innovations.

For instance,

In May, 2022, Fujifilm showcased its new endoscopy innovations for the detection, diagnosis, and treatment of diseases at Digestive Disease Week (May 21-24), 2022. The firm showcased its entire portfolio of endoscopic imaging solutions for core gastrointestinal (GI), therapeutic, interventional, and third space endoscopy including ELUXEO® VISION, G-EYE® 700 Series Colonoscopes, El-740D/S Dual-Channel Endoscope, TRACMOTION [Fujifilm’s new device for endoscopic submucosal dissection (ESD)]

“Single-use gastroscopes counter concerns related to the long waiting lists and staff shortages. Ease of setup and elimination of reprocessing are other advantages offered by the system which is expected to drive its adoption.”- Professor, Leading Hospital, United States

United States Expected to Continue to Hold a Major Share in the Gastrointestinal Endoscopic Devices Market

At the moment, the Global Gastrointestinal Endoscopic Devices Market is dominated by the United States. It is expected to continue to hold a major share in the coming years due to the rising number of endoscopic examinations, increasing aging population, favourable reimbursement climate for endoscopy procedures, growth in minimally invasive endoscopic therapy procedures, rising concerns over cleaning, disinfection & sterilization, and higher quality expectations.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold

The Global Gastrointestinal Endoscopic Devices Market is noticeable by the presence of both established and new players. Players operating in the Gastrointestinal MedTech Devices market adopt both organic and inorganic growth strategies such as new product launches, and partnerships to garner market share.

For instance,

In February 2022 Motus GI, received FDA Clearance to market the Pure-Vu® EVS System. The new Pure-Vu EVS System improves the speed of set-up, enhances navigation capabilities in tortuous anatomy, builds upon the excellent cleansing capabilities of the Pure-Vu system and enables physicians to rapidly overcome the challenges of poorly prepared colons during a colonoscopy

The increasing cases of GI disorders & requirements for endoscopes, laparoscopes/surgical endoscopes, endotherapy devices, and laparoscopic devices to diagnose and treat GI disorders are expected to drive the growth of the Gastrointestinal Endoscopic Devices Market over the upcoming years

Competitive Landscape Analysis of Gastrointestinal Endoscopic Devices Market

The global gastrointestinal endoscopic devices market is marked by the presence of players such as Olympus, Boston Scientific, Pentax (Hoya), Fujifilm, Cook Medical, Karl Storz, Ethicon, Medtronic, Stryker, Medi-Globe, Ambu, Arthrex, Richard Wolf, ERBE, Micro-Tech, among others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights:

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Devices & Pharma Services.

Contact Us:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[data-bridge-market-research]

Global Surgical Robots Market Competitive Analysis: Intuitive Surgical, Accuray Incorporated, Stryker, MEDTRONIC, Smith & Nephew

Global Surgical Robots Market By Product Type (Instruments, Robotic Systems, Accessories and Services), Brands (DA Vinci Surgical System, CyberKnife, Renaissance, Artas, ROSA, Others), Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy, Others), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026

Request Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-surgical-robots-market

Some of the major players operating in the global surgical robots market are

Intuitive Surgical,

Accuray Incorporated,

Stryker,

MEDTRONIC,

Smith & Nephew,

THINK Surgical, Inc.,

TransEnterix Surgical, Inc.,

Zimmer Biomet,

Verb Surgical Inc.,

Auris Health, Inc.,

Virtual Incision Corporation,

Restoration Robotics, Inc. and     others.

Global Surgical Robots Market is expected to reach USD 19,413.63 million by 2026 from USD 6,788.29 million in 2018, at a CAGR of 14.1% in the forecast period of 2019 to 2026. 

Drivers:

RISING AGEING POPULATION:

With increasing age, the patient pool for chronic disease is rising. Older populations are more prone to diseases such as diabetes, allergies, arthritis, cardiovascular diseases, infections, gastrointestinal and other problems.

According to the U.S. census     the number of people aged 65 and older in the United States on July 1,     2015 were 47.8 million.

In 2017, as per the United     Nation (World Population Prospects), the number of people ageing 60 or     above in the world was about 962 million, which were around 13% of the     total population across the globe. This is increasing at a rate of around     3% per year.

In 2017, according to United     Nations, 25% of the European population was 60 or over. It is estimated     that the rapid ageing would occur in other parts of the world too, so by     2050, except for Africa, all other regions of the world will nearly have a     quarter or more of their populations in the aging age group.

There are various health issues which are affected by the senior citizens such as osteoporosis, Alzheimer’s disease, osteoarthritis, diabetes, cardiovascular diseases among other diseases which are rising in the demand of surgeries. The demand for surgeries is growing but the number of doctors is decreasing, in such situation the surgical robots can be very helpful as they would help in reducing the time span of surgeries. Hence, the ageing population is expected to drive the market for the surgical robots.

RISING CASE OF ACUTE AND CHRONIC DISEASES:

The prevalence of diseases and conditions such as cardiovascular diseases, diabetes, Alzheimer’s disease, Parkinson’s disease, cancer and many others over the period of time.

According to American Cancer     Society, in 2016, it is estimated that in the U.S. around 1,685,210 new     cases of cancer will be diagnosed and approximately 595,690 people will     die due to this disease.

According to the World Health     Organization estimates, released in December 2016, there were 383000     deaths due to asthma in 2015.

According to National Center     for Chronic Disease Prevention and Health Promotion (NCCDPHP), stated that     in America, each year 6 in 10 adults have a chronic disease whereas 4 in     10 adults have two or more chronic diseases in the U.S.

According to Centers for     Disease Control and Prevention (CDC), stated that in the U.S., each year     about 610,000 people die due to heart diseases.

According to Centers for     Disease Control and Prevention (CDC), stated that in America, each year     about 735,000 people have a heart attack

With the increasing prevalence of chronic diseases the demand for the development and innovation of drugs and devices are increasing. This growing demand has provided an opportunity for the pharmaceutical companies to focus on introducing various products in the market in order to meet the rising demand for targeted drug delivery systems.

For instance, in 2016, Intuitive Surgical and Fosun Pharma agreed to establish a joint venture for the researching, developing, manufacturing and selling the robotic assisted catheter-based medical devices. This would help in producing the products which help in targeting the early diagnosis and cost-effective treatment of the lung cancer.

Restraints:

REGULATORY SCENARIO:

Robotics and the autonomous systems are being hailed as the fourth industrial revolution. Its impact will be felt more widely than either the computer or communications revolutions that preceded it. The exploitation of robotic technology in the healthcare setting has a great deal of potential and is an exciting area of development. Regulatory authorities are actively involved in various stages of robots development.

Two of the most important pieces of legislation in this area are:

Council Directive 93/42/EEC     concerning medical devices amended by Directive 2007/47/EC) (“Medical     Device Directive”)

Council Directive 90/385/EEC on     the approximation of the laws of the Member states relating to active     implantable medical devices (“AIMDD”)

Surgical robots fall under the regulation of the medical device directive. The FDA classifies medical devices into three categories – Class I, Class II and Class III- based on the risks associated with the device. Hence, too many rules and regulations by the government restrains the market growth.

HIGH COST OF THE EQUIPMENT AND SURGERY:

Surgical robots are the new technology that holds significant promise. One of the main factors which are restraining the growth of the market is the high cost of the equipment and the high cost of surgery involved.

For instance, robotic surgery     involves a huge amount of USD 1 million to USD 2 million and ongoing     annual maintenance costs of approximately of USD 250,000.

The cost of da Vinci system is     very huge and expensive. The system costs more than USD 1.5 Million per     unit.

The U.S. list price of     CyberKnife system is around USD 4.2 Million to USD 5.75 Million based on     the system configuration and the options which are purchased by the     customers.

Thus, the high cost of the equipment’s and the high cost of the surgery are restraining the market to grow.

Make inquiry before buying the report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-surgical-robots-market

Opportunity:

MERGERS AND ACQUISITIONS TO EXPAND BUSINESS:

Companies dealing in surgical robots have been leveraging mergers and acquisitions, internal R&D and new partnership to expand their business in other regions, especially in promising emerging market also to increase their surgical robots market size and to grab the opportunity of surgical robots in market.

In July 2016, Zimmer Biomet     (U.S.) acquired Medtech SA (France) for an estimated USD 132 million and     joined the surgical robotics market. This would help the company to allow     Medtech’s minimally invasive surgical robots for reaching a greater number     of patients who are suffering from the spine and neurological disorders     across the globe.

In April 2016, Auris Health,     Inc. (U.S.) and Hansen Medical, Inc. (U.S.)signed a definitive merger     agreement under which Auris has acquired Hansen Medical for USD 4.00 per     share in cash or a total equity value of approximately USD 80 million.

Mergers and acquisitions will lead to expansion of business as these mergers and acquisitions will create an opportunistic scenario for surgical robotics market leading to new product development.

Challenge:

INCREASING COMPETITORS:

Intuitive Surgical is the leader in the robotics surgery space. The Da Vinci Surgical Systems developed by Intuitive Surgical was launched in 1999 that have been used in more than 3 million procedures till date around the world. Recently, Toronto based Titan Medical, unveiled recently its SPORT (Single Port Orifice Robotic Technology) surgical robot, which is similar to the Da Vinci system.

Other players also in the market include Auris surgical robotics, Cambridge, Vecna technologies, Sofar and Health robotics, Mazor Robotics, Cambridge Medical Robotics and Swisslog holds a very good position both in international market and domestic market but due to the rise in demand of innovative technology in the market.

Market Trends:

Global surgical robots market is segmented into three notable segments which are product type, brands and application.

On the basis of product type, the market is segmented into robotic systems, instruments, accessories and services. In 2019, instruments segment is projected to lead with 59.3% shares and is growing with the highest CAGR of 15.1% in the forecast period of 2019 to 2026.

On the basis of brands, the market is segmented into Da Vinci surgical system, Renaissance, Cyberknife, Artas, ROSA and others. In 2019, Da Vinci surgical system segment is projected to lead with 79.6% shares and is growing with the highest CAGR of 15.2% in the forecast period of 2019 to 2026.

On the basis of application, the market is segmented into general surgery, urological, gynaecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, colorectal surgery and others. In 2019, general surgery segment is projected to lead with 31.2% shares and is growing with the highest CAGR of 17.3% in the forecast period of 2019 to 2026.

Buy Full Report @ https://databridgemarketresearch.com/checkout/buy/enterprise/global-surgical-robots-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

Tel: US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475 

Email: sopan.gedam@databridgemarketresearch.com

[itsrashmipatil-blog]

Surgical Robots Market - key Vendors, Trends, Analysis, Segmentation, Forecast to 2019-2030

The latest report, global Surgical robots market enables stakeholders to gain insights into their potential consumers to construct more effective marketing strategies for the forecast period, 2019 to 2030. Most importantly, the document empowers business owners to seek information about potential consumers and where they can find them. Apart from this, the literature sheds light on how major vendors operating in the global Surgical robots market are making the best use of their marketing campaigns. With an exclusive coverage of the top vendors, the study enables business owners to know more about the local market and locate potential consumers.  

Get FREE Sample Copy with TOC to understand the structure of the complete report @ https://www.marketindustryreports.com/pdf/20

Major Players in the Surgical Robots Market

·         Intuitive Surgical

·         Mazor Robotics

·         Zimmer Biomet (Medtech)

·         Auris Health

·         Inc. (Hansen Medical)

·         TransEnterix Surgical

·         Inc.

·         Stryker

·         Smith & Nephew

·         Renishaw plc

·         Medrobotics and THINK Surgical

·         Inc.

Get  Access to Data Pack @ https://www.marketindustryreports.com/data-pack/20

A recent market intelligence report on  Surgical robots market takes a closer look at the major driving forces, restraints and opportunities anticipated to shape the future of the  Surgical robots market for the forecast period, 2019 - 2030. Besides, this different adverse conditions and restraining factors expected to hinder the growth of the industry worldwide is also scrutinized. Trends from both past and present fast gaining momentum and stimulating market growth and development form an important part of the study.

The study on  Surgical robots market assesses the key drivers more extensively to help companies and individuals develop or tweak prototypes of a new product or service that is intended for the industry in the coming years. Most importantly, the study tries to understand why customers prefer certain products or services over others. Besides, a great emphasis is laid on the products that are innovated based on the lifestyle of the consumers. Most importantly, the report documents the dramatic shift in the lifestyle that has influenced the past buying habits of the customers.

Buy this report @ https://www.marketindustryreports.com/checkout/20

Market Segmentation:

Market segment by Type Robotic Systems Instruments and Accessories

Market segment by Application

Cardiac Surgery Gastrointestinal Surgery Urological Surgery Others

Market segment by Regions/Countries United States Europe

China Japan Southeast Asia India Central & South America

About Us

Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

Contact Us

2nd Floor, Manikchand Ikon, B-Wing, Dhole Patil Road, Sangamwadi, Pune 411 001 Email: sales@marketindustryreports.com Phone:   +1 347 767 5477 ( US )   + 91 8956 767 535 ( IN ) + 44 131 463 4161 ( UK ) Website: https://www.marketindustryreports.com Content Source @ https://www.marketindustryreports.com/epigenetics-market/27 Follow Us- LinkedIn | Twitter | Facebook

[randybenedict]

Olympus rejiggers medical biz

Olympus (TYO:7733) last week announced its plan to rejigger its medical device business with an eye toward gaining share in the U.S. market.

The Japanese conglomerate weathered an accounting scandal in 2011 after firing its first foreign CEO, Michael Woodford, after he blew the whistle on unexplained payments worth around $1.7 billion and demanded the resignation of the former chairman and vice president. In September 2012 the company and 3 former executives pleaded guilty in Japan to cover-up charges.

By 2014 Olympus was caught up in an FDA warning about power morcellators, which were found to pose a cancer risk; the federal safety watchdog that year ordered so-called “black box” warnings for the devices.

In 2015 the issue was duodenoscopes, which were implicated in rash of deadly “superbug” infections caused by inadequate sterilization during reprocessing. Olympus and a former senior executive pleaded guilty last month to failing to file required adverse event reports involving infections connected to the ‘scopes and continuing to sell the devices in the U.S.; the company paid $80 million in fines and another $5 million in criminal forfeiture.

Then, in May 2016, the company agreed to pay roughly $306 million to 50 states, Washington, D.C., and the federal government to resolve kickbacks allegations stemming from a whistleblower lawsuit accusing it of doling out grants, fellowships, consulting payments, free trips, payments for recreation and leisure activities, gifts and no-charge loans and free use of equipment to physicians.

The changes announced last week start at the very top, with the Japanese conglomerate’s board. Olympus said it plans to ask shareholders to approve a change from a Japanese auditing system to a three-committee board and the addition of three new directors: ValueAct Capital Management partner Robert Hale and a pair of yet-to-be-named medtech executives the company plans to recruit from “global medical technology companies.”

In the executive suite, Olympus said president Hiroyuki Sasa will move to its board April 1, with CFO Yasuo Takeuchi assuming the role of president & CEO. The company also named Akihiro Taguchi as COO, Haruo Ogawa as CTO, Yasushi Sakai as CFO and Stefan Kaufmann as chief administrative officer.

The medical device business will go from five segments to two, with the gastrointestinal, respiratory and surgical endoscopy lines united with software, reprocessing, repair and system integration under the endoscopic solutions business run out of Japan. The therapeutic solutions business, run out of the U.S., will include single-use endotherapy devices for GI and respiratory, energy and surgical single-use devices, urology, gynecology and ear, nose & throat products.

Finally, Olympus said it’s freezing its fiscal 2020 R&D spend at the fiscal 2018 level and developing a long-term savings program.

“The transform initiatives we are announcing today are the culmination of the multi-year effort to rebuild Olympus led by Hiroyuki Sasa when he became CEO in 2012 after a highly challenging period. He introduced the medium-term vision and then drove sustainable business growth during the initial years of the ’16 corporate strategic plan. Through Mr. Sasa’s leadership, we strengthened internal control frameworks as a foundation for enhancing global compliance and governance, implemented a matrix organizational structure to maximize the use of corporate resources, and reinforced the quality and regulatory assurance function. We also began to reorganize our operations by including leadership from Europe and the Americas as part of our executive management team and introduced the cross-business application of best practices,” Takeuchi said in prepared remarks. “As we near our 100-year anniversary as a leading company in Japan, this new plan better supports and harmonizes our global operations as a global medtech company. We believe this organization will drive improved organic growth and significantly more efficient operations, as we look to position Olympus for another 100 years of success. This plan is also fundamental to our commitment to accelerate shareholder value creation.

“I want to thank Mr. Sasa for his extraordinary service to Olympus. I am also honored to continue my own service to Olympus in this new role. Through the implementation of this go-forward plan, we will improve our performance and create a more efficient company that will fulfill our purpose of making people’s lives healthier, safer and more fulfilling,” Takeuchi said.

The post Olympus rejiggers medical biz appeared first on MassDevice.

from MassDevice http://bit.ly/2AJpg74

[pandeprabhakar01-blog]

Surgical Robots Market Forecast by Technology, Application, Dynamics, Development Trends and Outlook 2018-2025

The report covers the present scenario and the growth prospects of the global surgical robots for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market. Global surgical robots market will cross USD 16,793.2 million by 2025. It was valued at USD 5,986.1 million. The market is growing at a CAGR of 13.8% in the forecast period 2018 to 2025.

Get Free Sample Copy of Report at https://www.researchformarkets.com/sample/global-surgical-robots-market-65529

The key market players for global surgical robots market are listed below: Intuitive Surgical., Accuray Inc., MAZOR Robots, Restoration Robots, Inc, Medtech Global, Hansen Medical, Verb Surgical Inc, TransEnterix, Stryker  corporation, Auris Surgical Robots, MedRobots Corporation, Virtual Incision Corporation, Think Surgical, Inc, Preceyes B.V and Medtronic.

The market is further segmented into:

•        Product Type

•        Brand

•        Application

Based on geography, the market is segmented into 5 geographical regions:

•        North America

•        Europe

•        Asia-Pacific

•        South America

•        Middle East and Africa

Browse Complete Report at https://www.researchformarkets.com/reports/global-surgical-robots-market-65529

Table of Content

1 INTRODUCTION

2 MARKET SEGMENTATION

3 MARKET OVERVIEW

4 PREMIUM INSIGHTS

5 REPORT DESCRIPTION

6 GLOBAL SURGICAL ROBOTS MARKET, BY PRODUCT TYPE

7 GLOBAL SURGICAL ROBOTS MARKET, BY BRANDS

8 GLOBAL SURGICAL ROBOTS MARKET, BY APPLICATION

9 GLOBAL SURGICAL ROBOTS MARKET, BY GEOGRAPHY

10 GLOBAL SURGICAL ROBOTS MARKET,  COMPANY LANDSCAPE

11 COMPANY PROFILES

11.1 INTUITIVE SURGICAL, INC.

11.1.1 COMPANY OVERVIEW

11.1.2 SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.1.2.1 DRIVERS EXPLAINED

11.1.2.2 WEAKNESSES EXPLAINED

11.1.2.3 OPPORTUNITIES EXPLAINED

11.1.2.4 THREATS EXPLAINED

11.1.3 REVENUE ANALYSIS: INTUITIVE SURGICAL, INC.

11.1.4 PRODUCT PORTFOLIO

11.1.5 RECENT DEVELOPMENTS

11.2 MAZOR ROBOTICS

11.2.1 COMPANY OVERVIEW

11.2.2 SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.2.2.1 DRIVERS EXPLAINED

11.2.2.2 WEAKNESSES EXPLAINED

11.2.2.3 OPPORTUNITIES EXPLAINED

11.2.2.4 THREATS EXPLAINED

11.2.3 REVENUE ANALYSIS: MAZOR ROBOTICS

11.2.4 PRODUCT PORTFOLIO

11.2.5 RECENT DEVELOPMENTS

Place Direct Purchase Order of Surgical Robots Market at https://www.researchformarkets.com/buy-now/global-surgical-robots-market-65529/one

Scope of Report:

•        On the basis of Product type global surgical robots market is segmented into instruments, robotic systems and accessories and services. In 2018, instruments is estimated to rule with 58.8% shares and will cross USD 10,518.2 million by 2025, rising at the CAGR of 14.8%. Product type are further sub segmented into instruments, robotic systems, accessories and services.

•        On the basis of brands global surgical robots market is segmented into DA vinci surgical system, cyberknife, renaissance, artas, rosa and others. In 2018, DA Vinci Surgical System segment is estimated to rule with 79.8% shares and will cross USD 4,085.3 million by 2025, rising at the highest CAGR of 14.4%

•        On the basis of application global surgical robots market is segmented into general surgery, urological, gynaecological, gastrointestinal, radical prostatectomy, cardiothoracic surgery, colorectal surgery, radiotheraypy, and others. In 2018, General Surgery segment is estimated to rule with 29.8% shares and will cross USD 6,226.4 million by 2025, rising at the highest CAGR of 17.4%

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Info:

Name: Research For Markets

Email: alan.naidu@researchformarkets.com

Phone: +44 8000-4182-37

[pancholir72-blog]

Global Surgical Robots Market Growth, Significant Trends Till 2024

Global Surgical Robots Market is expected to reach USD 14.7 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 13.7% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=surgical-robots-market

Segmentation: Global Surgical Robots Market

By Product (Robotic Systems, Instruments and Accessories, Service), Brands (da Vinci Surgical System, CyberKnife, Renaissance, Artas, Rosa and Others), Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Drivers: Global Surgical Robots Market

Some of the major factors driving the market for surgical robots market are increasing cases of acute and chronic diseases, and rising aging population. These factors increase the demand for surgical robotics instruments, systems, and accessories and services. Increasing prevalence of chronic diseases, high precision, better benefits to patients and surgeons, and technological advancements are other factors driving the growth of the surgical robots market.

RISING AGING POPULATION

 pool for chronic diseases. Older populations are more prone to diseases such as arthritis, cardiovascular diseases, gastrointestinal and other problems. Aging population is expected to drive the market for the surgical robots.

Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=surgical-robots-market

RISING CASES OF CHRONIC DISEASES

In recent years, the prevalence of chronic diseases (such as cancer, cardiovascular diseases, and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand for surgical robots.

BETTER BENEFITS TO PATIENTS AND SURGEONS

The robots provides the surgeon with an increased level of dexterity and allow the surgeons to operate in small spaces inside the body that would otherwise require open surgery. More precise surgery, less loss of blood and risk of infection, and superior dexterity will drive the market for surgical robots.

TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN SURGICAL ROBOTS MARKET

The surgical robots market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of surgery.

Major Players: Global Surgical Robots Market

Some of the major players operating in this market are:

·         Intuitive Surgical, Inc.,

·         Verb Surgical Inc.,

·         Auris Surgical Robots,

·         MedRobots Corporation,

·         Restoration Robots, Inc.,

·         Virtual Incision Corporation,

·         Think Surgical, Inc.,

·         Medtech Global,

·         TransEnterix,

·         Titan Medical Inc.,

·         Stryker,

·         Accuray Inc.,

·         MAZOR Robots,

·         Hansen Medical,

·         ReWalk Robots,

·         Hocoma AG

·         among others.

Access Report: https://databridgemarketresearch.com/reports/surgical-robots-market/

About Us:                                                                        

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

[databridgemarketresearch1-blog]

Global Surgical Robots Market is Expected to Grow at CAGR 13.7% From 2017 to 2024 - New Study By Data Bridge Market Research

Data Bridge Market Research new Insight’s on “Global Surgical Robots Market, is projected to reach USD 14.5 billion by 2024, from USD 5.2 billion in 2016, at a CAGR of 13.7% during the forecast period from 2017 to 2024.”

The market is segmented

by Product (Robotic Systems, Instruments and Accessories, Service),

By Brands (Da Vinci Surgical System, Cyberknife, Renaissance, Flex, Artas, Rosa and Others),

By Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy and Others),

By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends And Forecast To 2024

The actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024.

Request For Sample- https://databridgemarketresearch.com/request-a-sample/?dbmr=surgical-robots-market-2

Recent Developments: Global Surgical Robots Market

·         In a short span of time robots have made their place in healthcare industry especially in the surgical system and all the credits goes to the advantages associated with it. According to the report of World Health Organization 48% of adverse events (medical errors) occurs in the operating room which can be reduced through Robots surgery, as it enhances the dexterity in many ways. There are other benefits of the Robots surgery over the traditional methods of surgery such as surgical precision, increased range of motion, enhanced visualization and improved access. The technological superiority and precision is the main factor driving the market for Robots surgery in the period of 2017 to 2024.

·         The main restraints in the surgical robots market are that these are highly technical surgery which requires the surgeon to be trained in this procedure. These surgeries require to be performed at the centre of excellence, supporting high tech robotic programs. Another restraint is the cost factor associated with it.

Segmentation: Global Surgical Robots Market Categories

·         The global surgical robots market is segmented based on product, brands, application and by geography.

·         On the basis of product type, the global surgical robots market is segmented into systems, instruments and accessories and service.

·         Based on brands the market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others. The Da Vinci Surgical System is currently dominating the surgical robots market due to the benefits given by it such as greater surgical precision and enhanced dexterity.

·         On the basis of application the market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others.

Request for TOC- https://databridgemarketresearch.com/toc/?dbmr=surgical-robots-market-2s

·         Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

·         The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2017, North America is expected to dominate the surgical Robots market followed by Europe and APAC. However the APAC region is expected to grow at the highest CAGR of 21.5% in the forecast period 2017 to 2024.

Company Share Analysis: Global Surgical Robots Market

The market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in the global surgical robots market are

·         Surgical, Inc.,

·         Verb Surgical Inc.,

·         Auris Surgical Robots,

·         MedRobots Corporation,

·         Restoration Robots, Inc.,

·         Virtual Incision Corporation,

·         Think Surgical, Inc.,

·         Medtech Global,

·         TransEnterix,

·         Titan Medical Inc,

·         Stryker,

·         Accuray Inc.,

·         MAZOR Robots,

·         Hansen Medical,

·         Capsa Healthcare,

·         LLC, Aesynt Inc, 

·         iRobot Corporation,

·         ReWalk Robots,

·         and Hocoma AG among others.

About Us :-Data bridge Market Research is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Contact Us:

Data Bridge Market Research Toll Free: +1-888-387-2818 Mail: sopan.gedam@databridgemarketresearch.com

[marketresearchreportsnews-blog]

Surgical Robot Market expected to reach USD 20.8 billion by 2024 : Grand View Research, Inc.

The global surgical robot market is expected to reach USD 20.8 billion by 2024, according to a new study by Grand View Research, Inc. The prevalence of chronic disorders, such as chronic heart diseases and various types of cancer, is on a rise. These diseases frequently require surgery as a line of treatment. With the advent of surgical robot, these surgeries have become easier and less traumatic, thereby propelling the demand over the forecast period.

The surgical robotic system causes less postoperative complications and reduces the length of hospital stay for a patient. This further helps to save treatment cost as well as labor cost. Owing to these benefits, these devices are now favored by hospitals in developing as well as developed regions.

The introduction of evolved systems is expected to boost the market growth over the forecast period. The development of computer software coupled with such robotic systems result in higher precision and better viewing of the incision site. This is expected to propel the demand over the forecast period.

The rising popularity of minimally invasive procedures due to their patient-friendly nature is the vital driver for this industry. Surgical robot help in performing complicated procedures through navigation and magnification options.

Full research report on surgical robot market analysis:

http://www.grandviewresearch.com/industry-analysis/surgical-robot-market

 Further key findings from the study suggest: 

·         Robot systems held a lucrative share of around 42.0% in the product segment. Robot systems were followed by accessories and are also anticipated to witness a substantial growth owing to their frequent repurchase. 

·         On the other hand, services are anticipated to grow at a lucrative rate of around 20.0% over the forecast period. Periodic maintenance of the existing robotic systems is mandatory; hence, this segment is anticipated to witness a substantial growth. 

·         The da Vinci Surgical System by Intuitive Surgical, Inc. dominated this industry in 2015. This system is the first U.S.FDA approved system; hence, retains the first mover advantage. 

·         ROSA surgical system by Medtech is anticipated to witness a lucrative growth over the forecast period. These systems are intended for the brain and spinal cord surgeries. Recent approval for ROSA systems as well as expansion in European and North American Region by Medtech is anticipated to support the growth of this system. 

·         Gynecology held significant share of around 30.0% in application segment followed by general surgery segment which is anticipated to witness remunerative share over the forecast period. Rising prevalence of colorectal cancer further contributed towards the growth of this segment. 

·         North America is the dominating market with lucrative shares of around 60.0% in 2015. However, Asia Pacific is projected to witness sturdy growth over the forecast period with the fastest growth rate. Healthcare advancements as well economic developments with the aid of government is anticipated to support the growth.

·         The key players operating in this industry include Intuitive Surgical, Inc., Accuray, MAKO /Stryker, Medtech Surgical, Hansen Medical, TransEntrix, Titan Medical, Inc., and Renishaw Plc. 

·         New product launches and collaborative developments are key strategic initiatives undertaken by market players to sustain the competition 

·         For instance, in July 2015, Accuray and Raysearch Laboratories AB formed a strategic collaboration. Accuray will co-market and offer Raycare Oncology Information System (OIS) in designated major radiation markets 

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

 Grand View Research has segmented the global surgical robot market on the basis of type, products, and region:

Global Surgical Robots Market By Product, 2014 - 2024 (USD Million)

·         Robot System

·         Instrument & Accessories

·         Services

Global Surgical Robots Market By Brand, 2014 - 2024 (USD Million)

·         da Vinci Surgical System

·         CyberKnife

·         ROSA

·         MAKO

·         Renaissance

·         Other

Global Surgical Robots Market By Application, 2014 - 2024 (USD Million)

·         General Surgery

·         Urology

·         Orthopedic

·         Neurosurgery

·         Cardiovascular

·         Gynecology

·         Radiology

·         Transplant

·         Gastrointestinal

·         Others

Surgical Robots Market By Region, 2014 - 2024 (USD Million)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

o    France 

o    Italy

o    Spain

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

o    Saudi Arabia

Access press release by Grand View Research: https://www.grandviewresearch.com/press-release/global-surgical-robot-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

[sandlerresearch]

Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact) published on

https://www.sandlerresearch.org/central-venous-catheters-drug-delivery-devices-global-market-analysis-and-forecast-model-covid-19-market-impact.html

Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)

Central Venous Catheters (Drug Delivery Devices) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Summary

Central Venous Catheters (Drug Delivery Devices) – Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Drug Delivery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Central Venous Catheters market for the year 2020 and beyond. Central venous access procedures are performed in patients who require venous access in treatment to deliver medications, nutrients or collect blood samples to perform test. A central venous catheter (CVC) is used in 8-10% of hospital cases with approximately 5 million catheters being inserted in the US every year.

The use of CVCs has become the standard practice for the administration of chemotherapy, fluid therapy, medications. They are also used to administer nutrition to patients when there is inadequate gastrointestinal function. These are majorly used in patients with chronic intestinal obstruction, food intolerance, post-operative bowel anastomosis leak, sepsis, polytrauma, and major fractures.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Central Venous Catheters and evolving competitive landscape – – Insightful review of the key industry trends. – Annualized total Central Venous Catheters market revenue by segment and market outlooks from 2015-2030. – Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights – – Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market. – SWOT analysis for Central Venous Catheters market. – Competitive dynamics insights and trends provided for Central Venous Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. – Country specific overview of the healthcare system. – Country specific reimbursement policies. – Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered – Teleflex Inc, CR Bard Inc, Edwards Lifesciences Corp, Vygon SA, B. Braun Melsungen AG, Smiths Medical, Kimal plc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report? This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – – CMO executives who must have deep understanding of the Central Venous Catheters marketplace to make strategic planning and investment decisions. – Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. – Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to – – Understand the impact of COVID-19 on Central Venous Catheters market. – Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. – Develop business strategies by understanding the trends shaping and driving Central Venous Catheters market. – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Central Venous Catheters market in the future. – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. – Track device sales in the global and country-specific Central Venous Catheters market from 2015-2030. – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.